SCI Cleanroom Cleaning 2025/26
The Cellular and Molecular Therapies (CMT) function is a Specialist Services department forming part of NHS Blood and Transplant (NHSBT) Therapeutic Services. The laboratories process, store and distribute human cell based products and gene therapies for transplantation and other therapies. CMT consists of seven laboratories based within NHSBT facilities at Barnsley, Birmingham, Filton (Bristol), Liverpool, Oxford and Southampton. Currently, these laboratories require scheduled and adhoc deep cleans of their clean rooms, with frequencies detailed in Appendix 1. Each laboratory operates clean room facilities in accordance with EUGMP (Annex 1) requirements and is licensed by the Human Tissue Authority (HTA) in accordance with the Human Tissue (Quality and Safety for Human Application) Regulations 2007 and the Joint Accreditation Committee - ISCT and EBMT (JACIE). The activities of the NHSBT CMT stem cell processing laboratories involve processing, testing, storage and distribution of human progenitor cells for autologous and/or allogeneic transplantation. Liverpool, Barnsley, CBC, Birmingham and Filton laboratories are also regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) for cell and gene therapy medicinal product manufacture. A high level of hygiene and cleanliness is essential to preventing contamination and maintaining the sterility of these products. Additional information: A pre-market engagement meeting will take place early 2026, all interested parties will receive an on-line invite.
Source ID: UK-ocds-b5fd17-9bda1be9-395c-457d-afcb-776ebdda9b2d
Estimated value
As published by the source; may be updated by the buyer.
Scope overview
The Cellular and Molecular Therapies (CMT) function is a Specialist Services department forming part of NHS Blood and Transplant (NHSBT) Therapeutic Services. The laboratories process, store and distribute human cell based products and gene therapies for transplantation and other therapies. CMT consists of seven laboratories based within NHSBT facilities at Barnsley, Birmingham, Filton (Bristol), Liverpool, Oxford and Southampton. Currently, these laboratories require scheduled and adhoc deep cleans of their clean rooms, with frequencies detailed in Appendix 1. Each laboratory operates clean room facilities in accordance with EUGMP (Annex 1) requirements and is licensed by the Human Tissue Authority (HTA) in accordance with the Human Tissue (Quality and Safety for Human Application) Regulations 2007 and the Joint Accreditation Committee - ISCT and EBMT (JACIE). The activities of the NHSBT CMT stem cell processing laboratories involve processing, testing, storage and distribution of human progenitor cells for autologous and/or allogeneic transplantation. Liverpool, Barnsley, CBC, Birmingham and Filton laboratories are also regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) for cell and gene therapy medicinal product manufacture. A high level of hygiene and cleanliness is essential to preventing contamination and maintaining the sterility of these products. Additional information: A pre-market engagement meeting will take place early 2026, all interested parties will receive an on-line invite.
Full description
The Cellular and Molecular Therapies (CMT) function is a Specialist Services department forming part of NHS Blood and Transplant (NHSBT) Therapeutic Services. The laboratories process, store and distribute human cell based products and gene therapies for transplantation and other therapies. CMT consists of seven laboratories based within NHSBT facilities at Barnsley, Birmingham, Filton (Bristol), Liverpool, Oxford and Southampton. Currently, these laboratories require scheduled and adhoc deep cleans of their clean rooms, with frequencies detailed in Appendix 1. Each laboratory operates clean room facilities in accordance with EUGMP (Annex 1) requirements and is licensed by the Human Tissue Authority (HTA) in accordance with the Human Tissue (Quality and Safety for Human Application) Regulations 2007 and the Joint Accreditation Committee - ISCT and EBMT (JACIE). The activities of the NHSBT CMT stem cell processing laboratories involve processing, testing, storage and distribution of human progenitor cells for autologous and/or allogeneic transplantation. Liverpool, Barnsley, CBC, Birmingham and Filton laboratories are also regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) for cell and gene therapy medicinal product manufacture. A high level of hygiene and cleanliness is essential to preventing contamination and maintaining the sterility of these products. Additional information: A pre-market engagement meeting will take place early 2026, all interested parties will receive an on-line invite.
Buyer & contacts
Similar tenders
Democratic Engagement Projects: engaging under-registered groups in democracy
We will commission projects which aim to increase democratic participation among groups who are less likely to be registered to vote and those who face other barriers. More information on these groups can be found in the
Strategic Defence Review - Energetics Information Notice
UK government is acting on the Strategic Defence Review's recommendations by investing in an 'always on' pipeline for munitions including building at least six new energetics and munitions factories in the UK. The Use
Unlock the full IndexBox Tenders workspace
Get hourly updates across 100k+ opportunities, AI recommendations, and one-click pipeline workflows. Zero obligation.
Disclaimer: IndexBox Tenders does not issue, announce, or publish this tender. This information is aggregated from publicly available sources and is provided for informational purposes only. IndexBox Tenders is not affiliated with, endorsed by, or acting on behalf of the tender issuer. Users should verify all information directly with the official tender source before making any decisions or taking any action.